A Study to Learn About the Study Medicine Etrasimod in Adults With Moderate to Severe Atopic Dermatitis (AD) Who Have Already Tried Treatments Taken by Mouth or by Injection

Stopped Per the results of the planned interim analysis, the study met futility criteria for efficacy so the trial was terminated. This decision was made for efficacy reasons only and is not due to any safety concerns.

Conditions

• Atopic Dermatitis
• Atopic Dermatitis, Unspecified
• Eczema
• Eczema, Atopic

Interventions

• DRUG: etrasimod
• DRUG: Placebo

Sponsor

Pfizer